MSB trading, page-597

I'm thinking more about a stable financial structure that will be easy to analyse. In Jack123456's post this morning we see where UBS is pushing some time lines out "by one to three years in the USA and three to four years in regions outside the USA." Time lines and no partnerships are a problem with this stock and is affecting the stock price.

It looks like they are on the right track with the product, research and trials but need to find a catalyst/method to get the problem areas covered IMO. As long as they stay on track I believe they will manage their capital raising requirements positively. And, the longer it lingers the more probable it becomes, they will rely more and more on their own resources, including the backing of their major shareholders, to move forward.

And while this goes on the stock remains speculative and one to trade as the opportunities present.

Alhambra.